Unlocking high-yield, cost-efficient EV manufacturing through fixed-bed bioreactors
Cell and Gene Therapy Insights 2026; 12(8)
10.18609/cgti.2026.116
Published: 6 October
Tech Showcase
Click image above to see a taster video
Watch the full Tech Showcase video to learn how to unlock high-yield, cost-efficient EV manufacturing through fixed-bed bioreactors.
Find out how to achieve:
✓
2- to 4-fold increased EV titer vs. flask-based systems
✓
6× higher viable cell density signal
✓
59% reduction in facility footprint compared to vertical wheel bioreactor production
✓
2-fold increase in protein content per EV and a 3-fold increase in the number of identified proteins
✓
Estimated yearly cost savings of USD 0.23M to 1.7M
✓
64% reduction in labour costs
View the interactive summary and video for free by clicking the link below.